Outcomes of patients with PSA above 20 ng/ml and benign prostatic biopsy: indications for rebiopsy

被引：0
|
作者：
Jones, CM [1 ]
Shaida, N [1 ]
Malone, PR [1 ]
机构：
[1] Royal Berkshire & Battle NHS Trust, Reading, Berks, England
来源：
BJU INTERNATIONAL | 2005年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P69
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [41] Prebiopsy bpMRI and hematological parameter-based risk scoring model for predicting outcomes in biopsy-naive men with PSA 4–20 ng/mL
    Yuxin Zheng
    Wang Li
    Yang Zhang
    Chi Zhang
    Junqi Wang
    Peng Ge
    Scientific Reports, 12
  • [42] IS IT SUITABLE TO ELIMINATE BONE SCAN FOR PROSTATE CANCER PATIENTS WITH PSA ≤20 NG/ML IN KOREAN POPULATION?
    Yom, C. D.
    Lee, S. H.
    Chung, M. S.
    Park, K. K.
    Chung, B. H.
    Mah, S. Y.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 271 - 271
  • [43] Is there a subset of patients with PSA >=20 ng/ml who do well after conformal beam radiotherapy?
    Algan, O
    Pinover, W
    Hanlon, A
    AlSaleem, TI
    Hanks, GE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 287 - 287
  • [44] Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
    Koo, Jin Mo
    Shim, Bong Suk
    KOREAN JOURNAL OF UROLOGY, 2010, 51 (12) : 831 - 835
  • [45] Radical prostatectomy for locally advanced prostate cancer with PSA ≥20 ng/ml
    Joniau, S.
    Gontero, P.
    Marchroro, G.
    Tiani, A.
    Frea, B.
    Van Poppel, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 103 - 103
  • [46] Histopathological Findings in Extended Prostate Biopsy with PSA ≤ 4 ng/mL EDITORIAL COMMENT
    Billis, Athanase
    INTERNATIONAL BRAZ J UROL, 2008, 34 (03): : 290 - 291
  • [47] Impact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mL
    Berger, AP
    Cheli, C
    Levine, R
    Klocker, H
    Bartsch, G
    Horninger, W
    UROLOGY, 2003, 62 (05) : 840 - 844
  • [48] The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20ng/mL
    Wang, Zhi-bing
    Wei, Chao-gang
    Zhang, Yue-yue
    Pan, Peng
    Dai, Guang-cheng
    Tu, Jian
    Shen, Jun-kang
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [49] Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings
    Yiji Peng
    Chengcheng Wei
    Ying Li
    Fuhan Zhao
    Yuan Liu
    Tao Jiang
    Zhipeng Chen
    Jun Zheng
    Jiong Fu
    Peng Wang
    Wenhao Shen
    BMC Urology, 25 (1)
  • [50] Outcomes of men who present with elevated serum PSA (>20 ng/mL) to an inner-city hospital
    Anai, Satoshi
    West, Shawn
    Chang, Myron
    Nakamura, Kogenta
    Pendleton, John
    Rosser, Charles J.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2007, 99 (08) : 895 - 899
12345